Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin

Leukemia

Volumn 19, Issue 10, 2005, Pages 1760-1767

  Quentmeier, H ^a   Martelli, M P ^b   Dirks, W G ^a   Bolli, N ^c   Liso, A ^d   MacLeod, R A F ^a   Nicoletti, I ^e   Mannucci, R ^e   Pucciarini, A ^c   Bigerna, B ^c   Martelli, M F ^c   Mecucci, C ^c   Drexler, H G ^a   Falini, B ^c  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^b UNIVERSITY OF BARI   (Italy)

^c Institute of Hematology   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e Institute of Internal Medicine and Oncological Sciences   (Italy)

Author keywords

AML; Mutations; Normal karyotype; Nucleophosmin; OCI AML3 cell line

Indexed keywords

CD34 ANTIGEN; CELL MARKER; CYTOSINE; GUANINE; NUCLEOPHOSMIN; THYMINE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER MODEL; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYTOPLASM; EXON; GENE DUPLICATION; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LEUKEMIA CELL LINE; MACROPHAGE; MOLECULAR BIOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 27144501134     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2403899     Document Type: Article

References (27)

1. Gilliland DG, Jordan CT, Felix CA. The molecular basis of leukemia. Hematol Am Soc Hematol Educ Program 2004, 80-97.
2. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322-2333.
3. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605-1616.
4. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254-266.
5. Cazzaniga G, Dell'Oro MG, Mecucci C, Giarin E, Masetti R, Rossi V et al. Nucleophosmin mutations in chilhood acute myelogenous leukemia with normal karyotype. Blood 2005, in press.
6. Jaffe E, Harris NL, Stein H, JW V. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001.
7. Hingorani K, Szebeni A, Olson MO. Mapping the functional domains of nucleolar protein B23. J Biol Chem 2000; 275: 24451-24457.
8. Borer RA, Lehner CF, Eppenberger HM, Nigg EA. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989; 56: 379-390.
9. Cordell JL, Pulford KA, Bigerna B, Roncador G, Banham A, Colombo E et al. Detection of normal and chimeric nucleophosmin in human cells. Blood 1999; 93: 632-642.
10. Bertwistle D, Sugimoto M, Sherr CJ. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 2004; 24: 985-996.
11. Brady SN, Yu Y, Maggi Jr LB, Weber JD. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol Cell Biol 2004; 24: 9327-9338.
12. Korgaonkar C, Hagen J, Tompkins V, Frazier AA, Allamargot C, Quelle FW et al. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 2005; 25: 1258-1271.
13. Okuda M. The role of nucleophosmin in centrosome duplication. Oncogene 2002; 21: 6170-6174.
14. MacLeod RA, Drexler HG. Cytogenetic analysis of cell lines. Methods Mol Biol 2005; 290: 51-70.
15. Falini B, Mason DY. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: Clinical value of their detection by immunocytochemistry. Blood 2002; 99: 409-426.
16. Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H et al. PG-M1: A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993; 142: 1359-1372.
17. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-229.
18. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419.
19. Nishimura Y, Ohkubo T, Furuichi Y, Umekawa H. Tryptophans 286 and 288 in the C-terminal region of protein B23.1 are importantfor its nucleolar localization. Biosci Biotechnol Biochem 2002; 66: 2239-2242.
20. Nakagawa M, Kameoka Y, Suzuki R. Nucleophosmin in acute myelogenous leukemia. N Engl J Med 2005; 352: 1819-1820, author reply 1819-1820.
21. Wang C, Curtis JE, Minden MD, McCulloch EA. Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia 1989; 3 264-269.
22. Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C et al. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: Correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 2002; 100: 59-66.
23. Quentmeier H, Reinhardt J, Zaborski M, Drexler HG. FLT3 mutations in acute myeloid leukemia cell lines. Leukemia 2003; 17: 120-124.
24. Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005; 106: 899-902.
25. Schoch C, Bursch S, Kern W, Schnittger S, Hiddemann W, Haferlach T. Gain of an isochromosome 5p: A new recurrent chromosome abnormality in acute monoblastic leukemia. Cancer Genet Cytogenet 2001; 127: 85-88.
26. Boyer J. del(13q) in myeloid malignancies. Atlas of Genetics and Cytogenetics in Oncology and Hematology. URL: http://www.infobiogen.fr/services/chromcancer/
27. Grisendi S, Pandolfi PP. NPM mutations in acute myelogenous leukemia. N Engl J Med 2005; 352: 291-292.